Suntory to Buy Daiichi OTC Unit $1.2B

Suntory Holdings (TYO:2587) announced acquisition of Daiichi Sankyo’s (TYO:4568) over‑the‑counter drug unit for roughly 200 billion yen ($1.2 billion).
The deal aims to broaden Suntory’s health‑related portfolio amid structural decline in demand for its alcoholic beverages such as beer and whisky.
Daiichi Sankyo will divest its OTC healthcare arm as part of its strategic focus shift.